Andrea Burden

Prof. Dr. Andrea Burden is a Lecturer in the Department of Chemistry and Applied Biosciences at ETH Zürich, specializing in pharmacoepidemiology and drug safety. Her research focuses on optimizing drug therapies, particularly in osteoporosis treatment, diabetes management, and opioid deprescribing strategies. She leads studies on medication safety profiles, including JAK inhibitors and GLP-1 receptor agonists, and evaluates real-world evidence for treatment efficacy and fracture risk. Her work integrates pharmacovigilance data from global sources like the WHO VigiBase, alongside population-based cohort analyses. Key areas include:

• Pharmacoepidemiological analysis of drug utilization trends
• Development of clinical decision-support frameworks
• Investigation into drug-induced adverse events
• Evaluation of healthcare cost implications for fracture management

Her studies often employ advanced statistical methods such as propensity score matching and cohort studies to assess outcomes in rheumatoid arthritis, diabetes, and postoperative pain management. Dr. Burden collaborates with international registries and healthcare systems to translate epidemiological findings into clinical guidelines.